Related Experiment Video

Updated: Mar 7, 2026

Surgical Swine Model of Chronic Cardiac Ischemia Treated by Off-Pump Coronary Artery Bypass Graft Surgery
09:12

Surgical Swine Model of Chronic Cardiac Ischemia Treated by Off-Pump Coronary Artery Bypass Graft Surgery

Published on: March 27, 2018

10.0K

Risk factor control, adherence to medication and follow up visit, five years after coronary artery bypass graft

Arsalan Salari1, Tolou Hasandokht2, Marjan Mahdavi-Roshan2

  • 1Guilan Interventional Cardiovascular Research Center, Heshmat Hospital, Guilan University of Medical Sciences, Rasht, Iran.

Journal of Cardiovascular and Thoracic Research
|February 18, 2017
PubMed

Insights

Medication and follow-up adherence are crucial after coronary artery bypass grafting (CABG). Poor risk factor control and infrequent follow-up visits are common in CABG patients, impacting long-term cardiovascular health.

Area of Science:

  • Cardiology
  • Public Health

Background:

  • Inadequate medication adherence and missed follow-up visits are linked to increased cardiovascular mortality and complications.
  • Effective management of risk factors post-coronary artery bypass grafting (CABG) is essential for long-term patient outcomes.

Purpose of the Study:

  • To evaluate medication adherence and follow-up visit attendance in patients 5 years after CABG.
  • To assess the control of cardiovascular risk factors in this patient cohort.

Main Methods:

  • Retrospective cohort study including adult patients who underwent CABG in 2010.
  • Assessment of conventional and probable risk factor control (blood pressure, glucose, LDL).
  • Evaluation of adherence to medication and follow-up appointments.

Main Results:

  • 48% had uncontrolled blood pressure, 61% uncontrolled blood glucose, and 32% high LDL.
  • Over 63% of former smokers resumed smoking within 6-12 months post-CABG.
  • 10.7% exhibited poor medication adherence, and 30% had their last follow-up visit after 12 months.

Conclusions:

  • Poor control of cardiovascular risk factors is prevalent among CABG patients.
  • Suboptimal adherence to follow-up visits is a significant issue in the post-CABG population.
  • Strategies to improve medication adherence and regular follow-up are necessary for CABG patients.

Keywords:
Coronary Artery Bypass GraftMedication AdherenceRisk Factor ControlSmoking

More Related Videos

Author Spotlight: Enhancing Coronary Artery Revascularization05:25

Author Spotlight: Enhancing Coronary Artery Revascularization

Published on: September 15, 2023

1.4K
Digital Home-Monitoring of Patients after Kidney Transplantation: The MACCS Platform07:13

Digital Home-Monitoring of Patients after Kidney Transplantation: The MACCS Platform

Published on: April 12, 2021

5.3K

Related Concept Videos

Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
357
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
789
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
540
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
360
Peripheral Artery Disease V: Postoperative Nursing Management01:23

Peripheral Artery Disease V: Postoperative Nursing Management

During the postoperative period, it is crucial to focus on maintaining circulation, identifying and managing potential complications, and planning for discharge.Nursing AssessmentVital signs monitoring: Regularly monitor vital signs, including blood pressure, heart rate, respiratory rate, and temperature, to detect early signs of complications such as bleeding and infection.Circulation assessment: Monitor pulses, perform Doppler assessments, and check capillary refill, color, temperature, and...
488
Aortic Regurgitation III: Medical Management01:25

Aortic Regurgitation III: Medical Management

Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
526